Optimizing Access, Appropriateness, and Quality of Minimally Invasive Procedures for Veterans
Optimizing Access, Appropriateness, and Quality of Minimally Invasive Procedures for Veterans
批准号:
10561611
负责人:
Celina M Yong
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-02-01 至 2024-01-31
关键词:
AddressAffectAortic Valve StenosisBenefits and RisksCardiac Surgery proceduresCardiovascular systemCaringComplexCoronary Artery BypassDataDatabasesDecision AidDecision MakingDemographic FactorsDevelopmentDiffusionDisciplineDisparityElderlyEquityEvidence based interventionFaceGenderGeographic LocationsGrantGrowthHealth Care CostsHealth PersonnelHealth Services AccessibilityHealthcareInequityInterventionInterviewLeftLifeLogistic RegressionsMapsMedicalMedicareMentorsMethodologyMethodsModelingOperative Surgical ProceduresPatientsPersonsPhysiciansPopulationPreparationProceduresProviderQuality of lifeRaceRandomizedResearchResourcesRiskSamplingScienceServicesSiteSocioeconomic StatusSpecialized CenterStenosisStructureTechnologyTestingTherapeuticTimeTrainingTranslatingTravelVeteransWorkaccess disparitiesaortic valve disorderaortic valve replacementbarrier to carecareercomorbiditycontextual factorsdesigneffective interventionexperiencegeographic barrierhealth datahigh riskhuman old age (65+)implementation scienceimplementation strategyimprovedinnovationinsightmilitary veteranminimally invasivemortalitymulti-site trialnovelolder patientpatient engagementpatient populationpercutaneous coronary interventionpersonalized decisionpersonalized risk predictionprototyperoutine carestructural heart diseasetooltreatment comparisontreatment disparityuptakevalve replacementweb site
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The last five years have seen a paradigm shift in healthcare: new minimally invasive treatments are
now available that can effectively replace surgery for elderly, comorbid patients. The most striking example is
Transcatheter Aortic Valve Replacement (TAVR), the first major minimally invasive structural heart disease
treatment to be disseminated nationally. TAVR is a life-saving option for the approximately 87,000 Veterans
nationwide who suffer from severe aortic stenosis, and thereby face a 50% mortality rate within two years if
left untreated. Preliminary data suggest that the novel complexities associated with TAVR diffusion significantly
impact vulnerable patient populations. Based on prior data, one key mechanism for these disparities may be
that vulnerable patient populations are less equipped to make informed decisions about treatment.
Driven by the hypothesis that vulnerable Veteran populations experience unequal treatment with
TAVR, but that decision support to routinely assess appropriateness and reduce barriers to care for Veterans
can reduce these differences, the aims of this proposal are to: (1) Identify patient level factors that
influence cardiovascular procedural treatment on the spectrum from minimally invasive (newer: TAVR and
older: PCI) to invasive (older: CABG, SAVR) within the VA, categorizing high and low access groups, with non-
VA data comparison. Multivariate, hierarchical logistic regression will be used to determine the association of
patient level factors, including demographic and VA-specific contextual factors (e.g., percent service
connection, proximity to VA procedure site, use of Veterans Choice or Medicare) with procedural use,
identifying “low” and “high” access profile groups. I hypothesize that older, established cardiovascular
procedures will show fewer inequities in care compared to the newest paradigm of care, TAVR. (2) Identify
decisional needs and barriers to achieving appropriate TAVR treatment from the perspectives of Veterans
(stratified into low and high access groups as defined by Aim 1) and their healthcare providers. I will use an
explanatory mixed methods design to conduct semi-structured interviews with a stratified sample of low and
high access profile Veterans referred for TAVR from multiple states and their providers to inform development
of a pilot intervention in Aim 3. I hypothesize that poor understanding of individualized risks and benefits are a
major limitation to appropriate TAVR referrals, with geographic barriers and difficulty using Veterans Choice
options particularly identified among low access profile Veterans. (3) Build and pilot a novel individualized
decision-making tool and patient facing website to improve both appropriateness and access to care, along
with a strategy for implementation into routine VA care. Using TAVR as a model, I will develop and validate
the feasibility of a prototype physician-facing decision aid for incorporation into routine VA care that predicts
individualized risks and benefits of TAVR, as well as a patient-facing website that addresses barriers to
care, such as mapping proximity and quality of the nearest TAVR sites for geographically remote Veterans who
may require use of Veterans Choice.
Through the successful execution of this work, for the first time, potential inequities in access to
TAVR among vulnerable Veterans will be identified, and insights will be revealed into the gaps in decision
making support for Veterans and their physicians that may contribute to these differences. Additionally, this
work will advance the field by piloting the first evidence-based intervention to systematically improve the
appropriateness of care for Veterans receiving minimally invasive procedures by generating
individualized risk-benefit profiles for treatment, with further online innovative decisional support
resources. This will serve as a model for a host of novel minimally invasive treatments now becoming
available across multiple therapeutic disciplines.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
Optimizing Access, Appropriateness, and Quality of Minimally Invasive Procedures for Veterans
-
批准号:10186515
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Celina M Yong
-
依托单位:
Optimizing Access, Appropriateness, and Quality of Minimally Invasive Procedures for Veterans
-
批准号:10392911
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Celina M Yong
-
依托单位:
海外基金